The accuracy of severity assessment tools designed for community acquired pneumonia among elderly patients with hospital acquired pneumonia
DOI:
https://doi.org/10.3126/ajms.v7i3.14032Keywords:
Hospital acquired pneumonia, Pneumonia severity assessment scores, PSI, CURB 65, SMART- COPAbstract
Background: Pneumonia severity assessment is an essential initial step in the evaluation of patients with community acquired pneumonia. Many validated severity assessment tools were designed for use in this setting. However, there is no disease based validated scoring system are in use for hospital acquired pneumonia.
Aims and Objectives: The aim of this study was to assess the validity for the use of PSI, CURB-65, and SMART-COP scores in elderly with hospital acquired pneumonia.
Materials and Methods: Thirty patients with hospital acquired pneumonia and 41 patients with community acquired pneumonia were assessed using PSI, CURB-65, and SMART-COP scores. Short term outcomes were recorded i.e. in hospital mortality, or 30 days mortality and the need for mechanical ventilation or vasopressor drugs.
Results: The 30 day mortality was 66.67% and 41.5% among HAP and CAP patients respectively. In both groups, the patients who died were older than the survivors; they had lower partial pressure of oxygen and Glasgow Coma Scale score. Moreover, they had higher heart rate and higher PSI, CURB 65, and SMART- COP scores. Among patient with community acquired pneumonia survivors had higher serum albumin while among patient with hospital acquired pneumonia, the survivors had lower fasting blood glucose.
Conclusion: PSI predicted 30 day mortality and the use of mechanical ventilation but not the use of vasopressor drugs in hospital acquired pneumonia. SMART- COP and CURB 65 predicted the use of vasopressor drugs in this group.
Asian Journal of Medical Sciences Vol. 7(3) 2016 65-71
Downloads
1047
927
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- The journal holds copyright and publishes the work under a Creative Commons CC-BY-NC license that permits use, distribution and reprduction in any medium, provided the original work is properly cited and is not used for commercial purposes. The journal should be recognised as the original publisher of this work.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
